nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—TUBB—dilated cardiomyopathy	0.784	1	CbGaD
Vinorelbine—ABCB1—Lisinopril—dilated cardiomyopathy	0.0254	0.532	CbGbCtD
Vinorelbine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0223	0.468	CbGbCtD
Vinorelbine—Ototoxicity—Furosemide—dilated cardiomyopathy	0.0049	0.067	CcSEcCtD
Vinorelbine—TUBB8—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00338	0.0477	CbGpPWpGaD
Vinorelbine—Diuresis—Furosemide—dilated cardiomyopathy	0.00317	0.0434	CcSEcCtD
Vinorelbine—Vinblastine—TUBB—dilated cardiomyopathy	0.00283	0.504	CrCbGaD
Vinorelbine—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00279	0.0394	CbGpPWpGaD
Vinorelbine—Vincristine—TUBB—dilated cardiomyopathy	0.00279	0.496	CrCbGaD
Vinorelbine—Local reaction—Furosemide—dilated cardiomyopathy	0.00178	0.0243	CcSEcCtD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00171	0.0241	CbGpPWpGaD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00171	0.0241	CbGpPWpGaD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00165	0.0233	CbGpPWpGaD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.0016	0.0226	CbGpPWpGaD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00156	0.0221	CbGpPWpGaD
Vinorelbine—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00141	0.0199	CbGpPWpGaD
Vinorelbine—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00141	0.0199	CbGpPWpGaD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.0014	0.0198	CbGpPWpGaD
Vinorelbine—Thrombosis—Furosemide—dilated cardiomyopathy	0.00139	0.019	CcSEcCtD
Vinorelbine—Blister—Furosemide—dilated cardiomyopathy	0.00136	0.0186	CcSEcCtD
Vinorelbine—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00136	0.0192	CbGpPWpGaD
Vinorelbine—TUBB—cardiac ventricle—dilated cardiomyopathy	0.00134	0.0701	CbGeAlD
Vinorelbine—Lethargy—Spironolactone—dilated cardiomyopathy	0.00134	0.0183	CcSEcCtD
Vinorelbine—TUBB2A—cardiac ventricle—dilated cardiomyopathy	0.00133	0.0698	CbGeAlD
Vinorelbine—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00132	0.0186	CbGpPWpGaD
Vinorelbine—TUBB6—cardiac ventricle—dilated cardiomyopathy	0.00132	0.0688	CbGeAlD
Vinorelbine—TUBB—Loss of Nlp from mitotic centrosomes—ALMS1—dilated cardiomyopathy	0.00131	0.0185	CbGpPWpGaD
Vinorelbine—TUBB4A—Loss of Nlp from mitotic centrosomes—TUBB—dilated cardiomyopathy	0.00129	0.0182	CbGpPWpGaD
Vinorelbine—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00129	0.0182	CbGpPWpGaD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—TUBB—dilated cardiomyopathy	0.00128	0.0181	CbGpPWpGaD
Vinorelbine—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00127	0.0174	CcSEcCtD
Vinorelbine—TUBB—myocardium—dilated cardiomyopathy	0.00126	0.066	CbGeAlD
Vinorelbine—TUBB2A—myocardium—dilated cardiomyopathy	0.00125	0.0656	CbGeAlD
Vinorelbine—TUBB6—myocardium—dilated cardiomyopathy	0.00124	0.0647	CbGeAlD
Vinorelbine—Injection site pain—Furosemide—dilated cardiomyopathy	0.0012	0.0165	CcSEcCtD
Vinorelbine—TUBB4B—Loss of Nlp from mitotic centrosomes—TUBB—dilated cardiomyopathy	0.00118	0.0167	CbGpPWpGaD
Vinorelbine—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00116	0.0163	CbGpPWpGaD
Vinorelbine—TUBB—Centrosome maturation—ALMS1—dilated cardiomyopathy	0.00116	0.0163	CbGpPWpGaD
Vinorelbine—TUBB4A—Centrosome maturation—TUBB—dilated cardiomyopathy	0.00114	0.0162	CbGpPWpGaD
Vinorelbine—TUBB4B—cardiac ventricle—dilated cardiomyopathy	0.00114	0.0598	CbGeAlD
Vinorelbine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00109	0.0149	CcSEcCtD
Vinorelbine—TUBB4A—Loss of Nlp from mitotic centrosomes—ALMS1—dilated cardiomyopathy	0.00108	0.0153	CbGpPWpGaD
Vinorelbine—TUBB4B—myocardium—dilated cardiomyopathy	0.00108	0.0563	CbGeAlD
Vinorelbine—TUBB—Regulation of PLK1 Activity at G2/M Transition—ALMS1—dilated cardiomyopathy	0.00106	0.015	CbGpPWpGaD
Vinorelbine—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—TUBB—dilated cardiomyopathy	0.00106	0.0149	CbGpPWpGaD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—TUBB—dilated cardiomyopathy	0.00105	0.0148	CbGpPWpGaD
Vinorelbine—TUBB8—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.00105	0.0148	CbGpPWpGaD
Vinorelbine—TUBB4B—Centrosome maturation—TUBB—dilated cardiomyopathy	0.00105	0.0148	CbGpPWpGaD
Vinorelbine—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00103	0.0141	CcSEcCtD
Vinorelbine—TUBB4B—Loss of Nlp from mitotic centrosomes—ALMS1—dilated cardiomyopathy	0.00099	0.014	CbGpPWpGaD
Vinorelbine—TUBB4A—heart—dilated cardiomyopathy	0.000962	0.0503	CbGeAlD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—TUBB—dilated cardiomyopathy	0.000961	0.0136	CbGpPWpGaD
Vinorelbine—TUBB4A—Centrosome maturation—ALMS1—dilated cardiomyopathy	0.000959	0.0135	CbGpPWpGaD
Vinorelbine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000944	0.0129	CcSEcCtD
Vinorelbine—TUBB2B—heart—dilated cardiomyopathy	0.00093	0.0487	CbGeAlD
Vinorelbine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000923	0.0126	CcSEcCtD
Vinorelbine—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00089	0.0122	CcSEcCtD
Vinorelbine—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—ALMS1—dilated cardiomyopathy	0.000881	0.0124	CbGpPWpGaD
Vinorelbine—TUBB—heart—dilated cardiomyopathy	0.00088	0.046	CbGeAlD
Vinorelbine—TUBB4B—Centrosome maturation—ALMS1—dilated cardiomyopathy	0.000877	0.0124	CbGpPWpGaD
Vinorelbine—TUBB2A—heart—dilated cardiomyopathy	0.000876	0.0458	CbGeAlD
Vinorelbine—TUBB6—heart—dilated cardiomyopathy	0.000864	0.0452	CbGeAlD
Vinorelbine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000825	0.0113	CcSEcCtD
Vinorelbine—Polyuria—Furosemide—dilated cardiomyopathy	0.000813	0.0111	CcSEcCtD
Vinorelbine—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—ALMS1—dilated cardiomyopathy	0.000805	0.0114	CbGpPWpGaD
Vinorelbine—Alopecia—Spironolactone—dilated cardiomyopathy	0.000802	0.011	CcSEcCtD
Vinorelbine—TUBB—G2/M Transition—ALMS1—dilated cardiomyopathy	0.000798	0.0113	CbGpPWpGaD
Vinorelbine—Deafness—Furosemide—dilated cardiomyopathy	0.000798	0.0109	CcSEcCtD
Vinorelbine—TUBB2B—cardiac atrium—dilated cardiomyopathy	0.000795	0.0416	CbGeAlD
Vinorelbine—TUBB4A—G2/M Transition—TUBB—dilated cardiomyopathy	0.000789	0.0111	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—ALMS1—dilated cardiomyopathy	0.000787	0.0111	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—TUBB—dilated cardiomyopathy	0.000778	0.011	CbGpPWpGaD
Vinorelbine—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.000775	0.0106	CcSEcCtD
Vinorelbine—TUBB—cardiac atrium—dilated cardiomyopathy	0.000753	0.0394	CbGeAlD
Vinorelbine—TUBB4B—heart—dilated cardiomyopathy	0.000751	0.0393	CbGeAlD
Vinorelbine—TUBB2A—cardiac atrium—dilated cardiomyopathy	0.000749	0.0392	CbGeAlD
Vinorelbine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000747	0.0102	CcSEcCtD
Vinorelbine—TUBB6—cardiac atrium—dilated cardiomyopathy	0.000739	0.0386	CbGeAlD
Vinorelbine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000738	0.0101	CcSEcCtD
Vinorelbine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000733	0.01	CcSEcCtD
Vinorelbine—Lethargy—Furosemide—dilated cardiomyopathy	0.000728	0.00996	CcSEcCtD
Vinorelbine—TUBB4B—G2/M Transition—TUBB—dilated cardiomyopathy	0.000722	0.0102	CbGpPWpGaD
Vinorelbine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000717	0.0098	CcSEcCtD
Vinorelbine—Malaise—Spironolactone—dilated cardiomyopathy	0.000713	0.00974	CcSEcCtD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—TUBB—dilated cardiomyopathy	0.000712	0.01	CbGpPWpGaD
Vinorelbine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000707	0.00967	CcSEcCtD
Vinorelbine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000669	0.00914	CcSEcCtD
Vinorelbine—Discomfort—Spironolactone—dilated cardiomyopathy	0.000665	0.00908	CcSEcCtD
Vinorelbine—TUBB4A—G2/M Transition—ALMS1—dilated cardiomyopathy	0.000661	0.00934	CbGpPWpGaD
Vinorelbine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000657	0.00898	CcSEcCtD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—ALMS1—dilated cardiomyopathy	0.000652	0.00921	CbGpPWpGaD
Vinorelbine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000645	0.00881	CcSEcCtD
Vinorelbine—TUBB4B—cardiac atrium—dilated cardiomyopathy	0.000642	0.0336	CbGeAlD
Vinorelbine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000631	0.00863	CcSEcCtD
Vinorelbine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00063	0.00861	CcSEcCtD
Vinorelbine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000605	0.00827	CcSEcCtD
Vinorelbine—TUBB4B—G2/M Transition—ALMS1—dilated cardiomyopathy	0.000605	0.00854	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—ALMS1—dilated cardiomyopathy	0.000596	0.00842	CbGpPWpGaD
Vinorelbine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000596	0.00815	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000557	0.00761	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000547	0.00747	CcSEcCtD
Vinorelbine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000538	0.00735	CcSEcCtD
Vinorelbine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000531	0.00726	CcSEcCtD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.00053	0.00749	CbGpPWpGaD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.00053	0.00749	CbGpPWpGaD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000525	0.00742	CbGpPWpGaD
Vinorelbine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00052	0.00711	CcSEcCtD
Vinorelbine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000513	0.00702	CcSEcCtD
Vinorelbine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000512	0.007	CcSEcCtD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000512	0.00723	CbGpPWpGaD
Vinorelbine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00051	0.00697	CcSEcCtD
Vinorelbine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000502	0.00686	CcSEcCtD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000496	0.007	CbGpPWpGaD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000485	0.00685	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000475	0.00649	CcSEcCtD
Vinorelbine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000456	0.00624	CcSEcCtD
Vinorelbine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000455	0.00622	CcSEcCtD
Vinorelbine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000454	0.0062	CcSEcCtD
Vinorelbine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000451	0.00616	CcSEcCtD
Vinorelbine—Angiopathy—Furosemide—dilated cardiomyopathy	0.000448	0.00612	CcSEcCtD
Vinorelbine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000446	0.0061	CcSEcCtD
Vinorelbine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000441	0.00603	CcSEcCtD
Vinorelbine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000441	0.00603	CcSEcCtD
Vinorelbine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00044	0.00601	CcSEcCtD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000435	0.00615	CbGpPWpGaD
Vinorelbine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000433	0.00592	CcSEcCtD
Vinorelbine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00043	0.00588	CcSEcCtD
Vinorelbine—Erythema—Furosemide—dilated cardiomyopathy	0.00043	0.00588	CcSEcCtD
Vinorelbine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000426	0.00583	CcSEcCtD
Vinorelbine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000419	0.00572	CcSEcCtD
Vinorelbine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000415	0.00567	CcSEcCtD
Vinorelbine—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000415	0.00586	CbGpPWpGaD
Vinorelbine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00041	0.0056	CcSEcCtD
Vinorelbine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000407	0.00556	CcSEcCtD
Vinorelbine—Rash—Spironolactone—dilated cardiomyopathy	0.000407	0.00556	CcSEcCtD
Vinorelbine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000406	0.00555	CcSEcCtD
Vinorelbine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000405	0.00553	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000405	0.00553	CcSEcCtD
Vinorelbine—Headache—Spironolactone—dilated cardiomyopathy	0.000404	0.00552	CcSEcCtD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—ITGB1—dilated cardiomyopathy	0.000398	0.00562	CbGpPWpGaD
Vinorelbine—Anaemia—Furosemide—dilated cardiomyopathy	0.000397	0.00543	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00039	0.00534	CcSEcCtD
Vinorelbine—Vertigo—Furosemide—dilated cardiomyopathy	0.000386	0.00528	CcSEcCtD
Vinorelbine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000385	0.00526	CcSEcCtD
Vinorelbine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000385	0.00526	CcSEcCtD
Vinorelbine—Nausea—Spironolactone—dilated cardiomyopathy	0.000383	0.00524	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000363	0.00497	CcSEcCtD
Vinorelbine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000351	0.0048	CcSEcCtD
Vinorelbine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000344	0.0047	CcSEcCtD
Vinorelbine—Flushing—Lisinopril—dilated cardiomyopathy	0.000344	0.0047	CcSEcCtD
Vinorelbine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000344	0.0047	CcSEcCtD
Vinorelbine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000341	0.00466	CcSEcCtD
Vinorelbine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000336	0.00459	CcSEcCtD
Vinorelbine—Anorexia—Furosemide—dilated cardiomyopathy	0.000334	0.00457	CcSEcCtD
Vinorelbine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000334	0.00456	CcSEcCtD
Vinorelbine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000331	0.00452	CcSEcCtD
Vinorelbine—Hypotension—Furosemide—dilated cardiomyopathy	0.000328	0.00448	CcSEcCtD
Vinorelbine—Alopecia—Lisinopril—dilated cardiomyopathy	0.000327	0.00448	CcSEcCtD
Vinorelbine—Erythema—Lisinopril—dilated cardiomyopathy	0.000323	0.00441	CcSEcCtD
Vinorelbine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000323	0.00441	CcSEcCtD
Vinorelbine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000315	0.00431	CcSEcCtD
Vinorelbine—Back pain—Lisinopril—dilated cardiomyopathy	0.000312	0.00426	CcSEcCtD
Vinorelbine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000305	0.00417	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000303	0.00414	CcSEcCtD
Vinorelbine—Fatigue—Furosemide—dilated cardiomyopathy	0.000302	0.00413	CcSEcCtD
Vinorelbine—Pain—Furosemide—dilated cardiomyopathy	0.0003	0.0041	CcSEcCtD
Vinorelbine—Constipation—Furosemide—dilated cardiomyopathy	0.0003	0.0041	CcSEcCtD
Vinorelbine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000299	0.00409	CcSEcCtD
Vinorelbine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000298	0.00407	CcSEcCtD
Vinorelbine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000295	0.00403	CcSEcCtD
Vinorelbine—Malaise—Lisinopril—dilated cardiomyopathy	0.000291	0.00398	CcSEcCtD
Vinorelbine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00029	0.00396	CcSEcCtD
Vinorelbine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000289	0.00395	CcSEcCtD
Vinorelbine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000289	0.00395	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000287	0.00392	CcSEcCtD
Vinorelbine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000285	0.0039	CcSEcCtD
Vinorelbine—Cough—Lisinopril—dilated cardiomyopathy	0.000281	0.00385	CcSEcCtD
Vinorelbine—Urticaria—Furosemide—dilated cardiomyopathy	0.000279	0.00381	CcSEcCtD
Vinorelbine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000277	0.00379	CcSEcCtD
Vinorelbine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000277	0.00379	CcSEcCtD
Vinorelbine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000275	0.00375	CcSEcCtD
Vinorelbine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000275	0.00375	CcSEcCtD
Vinorelbine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000275	0.00375	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000273	0.00373	CcSEcCtD
Vinorelbine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000271	0.00371	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.00027	0.00381	CbGpPWpGaD
Vinorelbine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000263	0.0036	CcSEcCtD
Vinorelbine—Infection—Lisinopril—dilated cardiomyopathy	0.000262	0.00357	CcSEcCtD
Vinorelbine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000258	0.00353	CcSEcCtD
Vinorelbine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000258	0.00352	CcSEcCtD
Vinorelbine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000257	0.00351	CcSEcCtD
Vinorelbine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000256	0.00349	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.000254	0.00358	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000252	0.00356	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000252	0.00356	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000252	0.00356	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000252	0.00356	CbGpPWpGaD
Vinorelbine—Asthenia—Furosemide—dilated cardiomyopathy	0.000252	0.00344	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.000251	0.00354	CbGpPWpGaD
Vinorelbine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000251	0.00343	CcSEcCtD
Vinorelbine—Pruritus—Furosemide—dilated cardiomyopathy	0.000248	0.00339	CcSEcCtD
Vinorelbine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000246	0.00336	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000243	0.00344	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000243	0.00344	CbGpPWpGaD
Vinorelbine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000243	0.00343	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—EMD—dilated cardiomyopathy	0.000241	0.00341	CbGpPWpGaD
Vinorelbine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00024	0.00328	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00024	0.00328	CcSEcCtD
Vinorelbine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000236	0.00323	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000236	0.00333	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000236	0.00333	CbGpPWpGaD
Vinorelbine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000235	0.00321	CcSEcCtD
Vinorelbine—Dizziness—Furosemide—dilated cardiomyopathy	0.000232	0.00317	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.00023	0.00325	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.00023	0.00325	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.00023	0.00324	CbGpPWpGaD
Vinorelbine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000229	0.00313	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000227	0.00311	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—ALMS1—dilated cardiomyopathy	0.000227	0.00321	CbGpPWpGaD
Vinorelbine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000227	0.0031	CcSEcCtD
Vinorelbine—Constipation—Lisinopril—dilated cardiomyopathy	0.000225	0.00308	CcSEcCtD
Vinorelbine—Pain—Lisinopril—dilated cardiomyopathy	0.000225	0.00308	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—TUBB—dilated cardiomyopathy	0.000224	0.00317	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.000224	0.00316	CbGpPWpGaD
Vinorelbine—Vomiting—Furosemide—dilated cardiomyopathy	0.000223	0.00305	CcSEcCtD
Vinorelbine—Rash—Furosemide—dilated cardiomyopathy	0.000221	0.00302	CcSEcCtD
Vinorelbine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000221	0.00302	CcSEcCtD
Vinorelbine—Headache—Furosemide—dilated cardiomyopathy	0.00022	0.003	CcSEcCtD
Vinorelbine—ABCB1—heart—dilated cardiomyopathy	0.000218	0.0114	CbGeAlD
Vinorelbine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000217	0.00297	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000215	0.00294	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.00021	0.00297	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00021	0.00297	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00021	0.00297	CbGpPWpGaD
Vinorelbine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000209	0.00286	CcSEcCtD
Vinorelbine—Nausea—Furosemide—dilated cardiomyopathy	0.000208	0.00285	CcSEcCtD
Vinorelbine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000208	0.00284	CcSEcCtD
Vinorelbine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000208	0.00284	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000207	0.00292	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000207	0.00292	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TUBB—dilated cardiomyopathy	0.000205	0.0029	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.000205	0.00289	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000204	0.00289	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000204	0.00289	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000204	0.00289	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000204	0.00289	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000203	0.00287	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—EMD—dilated cardiomyopathy	0.0002	0.00282	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000197	0.00279	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000197	0.00279	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000197	0.00277	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000194	0.00265	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.000192	0.00272	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000192	0.00271	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000191	0.0027	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000191	0.0027	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00019	0.00268	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00019	0.00268	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000189	0.00267	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000189	0.00267	CbGpPWpGaD
Vinorelbine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000189	0.00258	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—ALMS1—dilated cardiomyopathy	0.000188	0.00266	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000187	0.00264	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000187	0.00264	CbGpPWpGaD
Vinorelbine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000186	0.00255	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000184	0.00259	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—EMD—dilated cardiomyopathy	0.000183	0.00258	CbGpPWpGaD
Vinorelbine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00018	0.00246	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000178	0.00251	CbGpPWpGaD
Vinorelbine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000174	0.00238	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000174	0.00245	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000173	0.00244	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—ALMS1—dilated cardiomyopathy	0.000172	0.00243	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000168	0.00237	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000168	0.00237	CbGpPWpGaD
Vinorelbine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000167	0.00229	CcSEcCtD
Vinorelbine—Rash—Lisinopril—dilated cardiomyopathy	0.000166	0.00227	CcSEcCtD
Vinorelbine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000166	0.00227	CcSEcCtD
Vinorelbine—Headache—Lisinopril—dilated cardiomyopathy	0.000165	0.00225	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.000161	0.00227	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000158	0.00223	CbGpPWpGaD
Vinorelbine—Nausea—Lisinopril—dilated cardiomyopathy	0.000156	0.00214	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000156	0.0022	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000154	0.00217	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000154	0.00217	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TMPO—dilated cardiomyopathy	0.000144	0.00203	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000143	0.00201	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.000133	0.00188	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000132	0.00186	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.000122	0.00172	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TMPO—dilated cardiomyopathy	0.000119	0.00168	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—LMNA—dilated cardiomyopathy	0.000118	0.00166	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000117	0.00166	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000109	0.00154	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TMPO—dilated cardiomyopathy	0.000109	0.00154	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	9.99e-05	0.00141	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—LMNA—dilated cardiomyopathy	9.92e-05	0.0014	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—LMNA—dilated cardiomyopathy	9.92e-05	0.0014	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	9.89e-05	0.0014	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—LMNA—dilated cardiomyopathy	9.77e-05	0.00138	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—LMNA—dilated cardiomyopathy	9.58e-05	0.00135	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—LMNA—dilated cardiomyopathy	9.28e-05	0.00131	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—LMNA—dilated cardiomyopathy	9.07e-05	0.00128	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—LMNA—dilated cardiomyopathy	8.94e-05	0.00126	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—ACE—dilated cardiomyopathy	8.56e-05	0.00121	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—ACE—dilated cardiomyopathy	8.56e-05	0.00121	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	8.28e-05	0.00117	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—ACE—dilated cardiomyopathy	8.27e-05	0.00117	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—LMNA—dilated cardiomyopathy	8.14e-05	0.00115	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—ACE—dilated cardiomyopathy	8.01e-05	0.00113	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—ACE—dilated cardiomyopathy	7.83e-05	0.00111	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	7.7e-05	0.00109	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—LMNA—dilated cardiomyopathy	7.45e-05	0.00105	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	7.43e-05	0.00105	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—ACE—dilated cardiomyopathy	7.03e-05	0.000993	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—ACE—dilated cardiomyopathy	6.43e-05	0.000908	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—AGT—dilated cardiomyopathy	5.43e-05	0.000766	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—AGT—dilated cardiomyopathy	5.43e-05	0.000766	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—AGT—dilated cardiomyopathy	5.24e-05	0.00074	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—AGT—dilated cardiomyopathy	5.08e-05	0.000717	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—AGT—dilated cardiomyopathy	4.96e-05	0.000701	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.8e-05	0.000677	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.66e-05	0.000659	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.66e-05	0.000659	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—AGT—dilated cardiomyopathy	4.46e-05	0.000629	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.34e-05	0.000612	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.14e-05	0.000585	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.14e-05	0.000585	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—AGT—dilated cardiomyopathy	4.08e-05	0.000576	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4e-05	0.000565	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.88e-05	0.000547	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.8e-05	0.000537	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.79e-05	0.000535	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.66e-05	0.000517	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.59e-05	0.000507	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.4e-05	0.000481	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.15e-05	0.000445	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.15e-05	0.000445	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.11e-05	0.00044	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	2.97e-05	0.000419	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	2.96e-05	0.000418	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.79e-05	0.000394	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.68e-05	0.000378	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.53e-05	0.000357	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.38e-05	0.000336	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.94e-05	0.000274	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.83e-05	0.000258	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.65e-05	0.000233	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.63e-05	0.000231	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.56e-05	0.00022	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.46e-06	0.000134	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	7.28e-06	0.000103	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	7.09e-06	0.0001	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	6.86e-06	9.69e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	6.68e-06	9.43e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	6.38e-06	9.01e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	6.02e-06	8.49e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.49e-06	6.33e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.37e-06	6.17e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.93e-06	5.55e-05	CbGpPWpGaD
